Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling.
about
Mitochondria, cholesterol and cancer cell metabolismUnderstanding the Causes and Implications of Endothelial Metabolic Variation in Cardiovascular Disease through Genome-Scale Metabolic ModelingTranscriptomics resources of human tissues and organsPersonalized Cardiovascular Disease Prediction and Treatment-A Review of Existing Strategies and Novel Systems Medicine ToolsCancer Metabolism: A Modeling PerspectiveApplications of Genome-Scale Metabolic Models in Biotechnology and Systems MedicineForward Individualized Medicine from Personal Genomes to InteractomesReconstruction of Tissue-Specific Metabolic Networks Using CORDAAssessment of FBA Based Gene Essentiality Analysis in Cancer with a Fast Context-Specific Network Reconstruction MethodA Multi-scale Computational Platform to Mechanistically Assess the Effect of Genetic Variation on Drug Responses in Human Erythrocyte MetabolismThe space of enzyme regulation in HeLa cells can be inferred from its intracellular metabolomeIntegrated metabolic modelling reveals cell-type specific epigenetic control points of the macrophage metabolic networkAdaptation to different types of stress converge on mitochondrial metabolismReconstruction of genome-scale human metabolic models using omics data.Integrative analysis of human omics data using biomolecular networks.Analysing Algorithms and Data Sources for the Tissue-Specific Reconstruction of Liver Healthy and Cancer Cells.Translational learning from clinical studies predicts drug pharmacokinetics across patient populations.Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism.Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer.Genome-scale modeling and human disease: an overview.Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.Systems biology of host-microbe metabolomics.Context-Specific Metabolic Model Extraction Based on Regularized Least Squares Optimization.Estimating Metabolic Fluxes Using a Maximum Network Flexibility Paradigm.The gut microbiota modulates host amino acid and glutathione metabolism in miceModeling cancer metabolism on a genome scale.Extensive weight loss reveals distinct gene expression changes in human subcutaneous and visceral adipose tissue.Living on the edge: substrate competition explains loss of robustness in mitochondrial fatty-acid oxidation disorders.Building SuperModels: emerging patient avatars for use in precision and systems medicineBenchmarking Procedures for High-Throughput Context Specific Reconstruction Algorithms.MetaboTools: A Comprehensive Toolbox for Analysis of Genome-Scale Metabolic Models.IDENTIFYING CANCER SPECIFIC METABOLIC SIGNATURES USING CONSTRAINT-BASED MODELS.Personalized Prediction of Proliferation Rates and Metabolic Liabilities in Cancer Biopsies.Elucidating the interactions between the human gut microbiota and its host through metabolic modeling.Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD.Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133.Generalized framework for context-specific metabolic model extraction methods.A pathology atlas of the human cancer transcriptome.A systems approach reveals distinct metabolic strategies among the NCI-60 cancer cell lines.Integrating highly quantitative proteomics and genome-scale metabolic modeling to study pH adaptation in the human pathogen Enterococcus faecalis.
P2860
Q26741708-F31F1675-E39E-4AEE-91C9-733114B5B3D4Q26752302-6253EF16-9C23-4683-9E46-AE2CF5518A5AQ26752519-87E1167E-4388-43BE-B545-EA8B9DC15622Q26767513-AC3600A9-2A35-4D87-AAA3-4AB31E3A7331Q26770819-DA728483-7113-4BC2-A6AC-5907FA9B6ED7Q26771504-7BD9A90D-78CF-4CB0-8020-68862A8DEB1EQ26773100-710DB1FB-490B-49E5-8D18-CCB53EE30E5AQ28388815-33A45989-CFDB-4B7A-B9D4-C45908836CCBQ28551811-78A9BFF4-8719-43EA-9191-EA7FE4D338F4Q28553224-27B97EB3-9ADB-42ED-A4C6-750FB6922CB0Q28597558-738C9247-469B-418F-92FE-868F23B1171AQ28608553-34EB1289-676F-4FAF-969F-734E771F8455Q28828409-CD402639-8534-440D-91A2-31B86B7727AEQ30902292-3D994197-D5DD-4396-AD7A-C4A40AD20430Q31120979-8F717087-81D5-4529-BCEA-2E1F10BC7CEEQ31170155-906141A1-7536-49EA-8EF5-D7AE3810896EQ33767468-B8487527-666E-4EA8-8875-C994EDB4FD24Q34044149-62F2AD7A-4AA4-4F05-BC38-E22C126DBC0DQ34545824-9F7C0D13-F27A-46C4-8DDB-601B1DF9C9DCQ35005453-2CF6840B-F34B-4B0B-85EC-9798E729A503Q35619104-199F5FCC-C25F-4410-92B0-470A2D22C8B9Q35619563-8D94CD4E-6038-4C3F-A975-CE6C1E6502FEQ35687124-1BB77B72-F5CC-41D8-A90E-F96D3C0C7702Q35803311-FC94C862-01A7-40BC-AE5B-23AE73CC706DQ35811086-BC87C3A8-83F8-4A6B-9780-133E4E7FAE4CQ35850350-F608313D-9484-4637-B8B8-8E6F738B56F5Q36120645-7BA3BC37-595D-4530-91A6-E0A1EAAAC6D2Q36215331-28109B0D-C44D-4AEF-AD96-5DBF45130E9BQ36254297-FE1126D6-B1BE-4286-BC32-F17ADDA2C9D7Q36488428-16FF093F-6823-4581-A0D4-4C55AEDC4532Q37148097-B79E6D78-F075-4BE8-B03F-2D04AAB927D5Q37520927-82B9221D-67EF-4989-BB17-CA059B3AAFA2Q37532946-52CBEDDA-B179-4065-9598-41E5EDEFC932Q37725583-8F7EA4F1-1061-4CD0-8382-C28DAE38AC0FQ37727707-3259AC79-408F-4AAC-B9E8-F708777D62B9Q37734673-46CC001C-093D-470D-8D54-A3AF41F3653EQ38256965-1AE28482-975D-4E8C-9952-89A216C6C0AAQ38619228-0CCD772B-B485-4A11-923B-945B46301658Q38625636-AEFE3461-C9D1-45AC-9E32-554E07D1AEB2Q38671216-490EAD46-82E8-442C-BD79-589DF3E8B704
P2860
Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Identification of anticancer d ...... nome-scale metabolic modeling.
@ast
Identification of anticancer d ...... nome-scale metabolic modeling.
@en
type
label
Identification of anticancer d ...... nome-scale metabolic modeling.
@ast
Identification of anticancer d ...... nome-scale metabolic modeling.
@en
prefLabel
Identification of anticancer d ...... nome-scale metabolic modeling.
@ast
Identification of anticancer d ...... nome-scale metabolic modeling.
@en
P2093
P2860
P356
P1476
Identification of anticancer d ...... nome-scale metabolic modeling.
@en
P2093
Adil Mardinoglu
Anna Asplund
Caroline Kampf
Rasmus Agren
P2860
P356
10.1002/MSB.145122
P577
2014-03-19T00:00:00Z